Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2014

Open Access 01-12-2014 | Research

Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma

Authors: Masashi Ishikawa, Makoto Sonobe, Naoto Imamura, Terumasa Sowa, Kei Shikuma, Hiroshi Date

Published in: World Journal of Surgical Oncology | Issue 1/2014

Login to get access

Abstract

Background

The hedgehog (Hh) signaling pathway is aberrantly activated in various cancers. Expression of the GLI family of genes, which encode for transcriptional factors of the Hh pathway, has not been fully assessed in clinical samples of advanced lung adenocarcinoma. In this study, we retrospectively evaluated the expression of the GLI family of genes in advanced stage lung adenocarcinoma samples and determined their relation to patient survival.

Methods

The levels of GLI1, GLI2, and GLI3 mRNA expression were measured by quantitative real-time polymerase chain reaction in surgically obtained tissue samples from stage II-IV lung adenocarcinoma patients (n = 102). Pairwise comparisons between all three GLI mRNA expression were performed, and after dichotomizing the patients into low and high expression groups according to each GLI mRNA expression level, survival curves were calculated and multivariate analyses were conducted.

Results

Significant positive correlation was found between GLI1 and GLI3 mRNA expression (P <0.001). Tumors with higher expression (upper 15%) of GLI1 or GLI3 mRNA were associated with poor survival in stage II-IV (5-year overall survival rates: GLI1 mRNA low, 41.7% vs. high, 20.0%, P = 0.0074; GLI3 mRNA low, 43.1% vs. high, 13.3%, P = 0.0062) and stage III-IV (5-year overall survival rates: GLI1 mRNA low, 34.0% vs. high, 0%, P = 0.0012; GLI3 mRNA low, 33.4% vs. high, 7.7%, P = 0.057) lung adenocarcinoma patients. GLI2 mRNA expression did not appear to have great clinical significance. Multivariate analysis revealed higher GLI1 mRNA expression as an independent factor for unfavorable patient survival (P = 0.0030, hazard ratio = 3.1, 95% confidence interval = 1.5-6.2), as well as tumor differentiation and stage.

Conclusions

Expression of GLI1 and GLI3 mRNA was strongly correlated, and their overexpression, especially that of GLI1, was found to be predictive of aggressive tumor behavior. This study indicates that the Hh pathway may be a key oncogenic signaling network in tumor pathogenesis and, thus, a potential therapeutic target in advanced lung adenocarcinoma.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90.CrossRefPubMed
3.
go back to reference William WN, Lin HY, Lee JJ, Lippman SM, Roth JA, Kim ES: Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data. Chest. 2009, 136: 701-709.CrossRefPubMed William WN, Lin HY, Lee JJ, Lippman SM, Roth JA, Kim ES: Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data. Chest. 2009, 136: 701-709.CrossRefPubMed
4.
go back to reference Shaw AT, Yeap BY, Solomon BJ, Riely GJ, Gainor J, Engelman JA, Shapiro GI, Costa DB, Ou SH, Butaney M, Salgia R, Maki RG, Varella-Garcia M, Doebele RC, Bang YJ, Kulig K, Selaru P, Tang Y, Wilner KD, Kwak EL, Clark JW, Iafrate AJ, Camidge DR: Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol. 2011, 12: 1004-1012.PubMedCentralCrossRefPubMed Shaw AT, Yeap BY, Solomon BJ, Riely GJ, Gainor J, Engelman JA, Shapiro GI, Costa DB, Ou SH, Butaney M, Salgia R, Maki RG, Varella-Garcia M, Doebele RC, Bang YJ, Kulig K, Selaru P, Tang Y, Wilner KD, Kwak EL, Clark JW, Iafrate AJ, Camidge DR: Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol. 2011, 12: 1004-1012.PubMedCentralCrossRefPubMed
5.
go back to reference Ruiz I, Altaba A, Sanchez P, Dahmane N: Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer. 2002, 2: 361-372.CrossRef Ruiz I, Altaba A, Sanchez P, Dahmane N: Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer. 2002, 2: 361-372.CrossRef
6.
go back to reference Ingham PW, McMahon AP: Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001, 15: 3059-3087.CrossRefPubMed Ingham PW, McMahon AP: Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001, 15: 3059-3087.CrossRefPubMed
8.
go back to reference Kasper M, Regl G, Frischauf AM, Aberger F: GLI transcription factors: mediators of oncogenic Hedgehog signalling. Eur J Cancer. 2006, 42: 437-445.CrossRefPubMed Kasper M, Regl G, Frischauf AM, Aberger F: GLI transcription factors: mediators of oncogenic Hedgehog signalling. Eur J Cancer. 2006, 42: 437-445.CrossRefPubMed
9.
go back to reference Yang L, Xie G, Fan Q, Xie J: Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene. 2010, 29: 469-481.CrossRefPubMed Yang L, Xie G, Fan Q, Xie J: Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene. 2010, 29: 469-481.CrossRefPubMed
10.
go back to reference Teglund S, Toftgard R: Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim Biophys Acta. 2010, 1805: 181-208.PubMed Teglund S, Toftgard R: Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim Biophys Acta. 2010, 1805: 181-208.PubMed
11.
go back to reference Watkins DN, Berman DM, Baylin SB: Hedgehog signaling: progenitor phenotype in small-cell lung cancer. Cell Cycle. 2003, 2: 196-198.CrossRefPubMed Watkins DN, Berman DM, Baylin SB: Hedgehog signaling: progenitor phenotype in small-cell lung cancer. Cell Cycle. 2003, 2: 196-198.CrossRefPubMed
12.
go back to reference Park KS, Martelotto LG, Peifer M, Sos ML, Karnezis AN, Mahjoub MR, Bernard K, Conklin JF, Szczepny A, Yuan J, Guo R, Ospina B, Falzon J, Bennett S, Brown TJ, Markovic A, Devereux WL, Ocasio CA, Chen JK, Stearns T, Thomas RK, Dorsch M, Buonamici S, Watkins DN, Peacock CD, Sage J: A crucial requirement for hedgehog signaling in small cell lung cancer. Nat Med. 2011, 17: 1504-1508.PubMedCentralCrossRefPubMed Park KS, Martelotto LG, Peifer M, Sos ML, Karnezis AN, Mahjoub MR, Bernard K, Conklin JF, Szczepny A, Yuan J, Guo R, Ospina B, Falzon J, Bennett S, Brown TJ, Markovic A, Devereux WL, Ocasio CA, Chen JK, Stearns T, Thomas RK, Dorsch M, Buonamici S, Watkins DN, Peacock CD, Sage J: A crucial requirement for hedgehog signaling in small cell lung cancer. Nat Med. 2011, 17: 1504-1508.PubMedCentralCrossRefPubMed
13.
go back to reference Vestergaard J, Pedersen MW, Pedersen N, Ensinger C, Tumer Z, Tommerup N, Poulsen HS, Larsen LA: Hedgehog signaling in small-cell lung cancer: frequent in vivo but a rare event in vitro. Lung Cancer. 2006, 52: 281-290.CrossRefPubMed Vestergaard J, Pedersen MW, Pedersen N, Ensinger C, Tumer Z, Tommerup N, Poulsen HS, Larsen LA: Hedgehog signaling in small-cell lung cancer: frequent in vivo but a rare event in vitro. Lung Cancer. 2006, 52: 281-290.CrossRefPubMed
14.
go back to reference Sobin L, Gospodarowicz M, Wittekind C: TNM Classification of Malignant Tumours (UICC International Union Against Cancer). 2009, Oxford: Wiley-Blackwell Co., 7 Sobin L, Gospodarowicz M, Wittekind C: TNM Classification of Malignant Tumours (UICC International Union Against Cancer). 2009, Oxford: Wiley-Blackwell Co., 7
15.
go back to reference Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC: Pathology & Genetics of Tumours of the Lung, Pleura, Thymus and Heart (World Health Organization Classification of Tumours), Volume 10. 2004, Lyon: IARC Press Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC: Pathology & Genetics of Tumours of the Lung, Pleura, Thymus and Heart (World Health Organization Classification of Tumours), Volume 10. 2004, Lyon: IARC Press
16.
17.
go back to reference Yuan Z, Goetz JA, Singh S, Ogden SK, Petty WJ, Black CC, Memoli VA, Dmitrovsky E, Robbins DJ: Frequent requirement of hedgehog signaling in non-small cell lung carcinoma. Oncogene. 2007, 26: 1046-1055.CrossRefPubMed Yuan Z, Goetz JA, Singh S, Ogden SK, Petty WJ, Black CC, Memoli VA, Dmitrovsky E, Robbins DJ: Frequent requirement of hedgehog signaling in non-small cell lung carcinoma. Oncogene. 2007, 26: 1046-1055.CrossRefPubMed
18.
go back to reference Rodriguez-Blanco J, Schilling NS, Tokhunts R, Giambelli C, Long J, Liang Fei D, Singh S, Black KE, Wang Z, Galimberti F, Bejarano PA, Elliot S, Glassberg MK, Nguyen DM, Lockwood WW, Lam WL, Dmitrovsky E, Capobianco AJ, Robbins DJ: The hedgehog processing pathway is required for NSCLC growth and survival. Oncogene. 2013, 32: 2335-2345.CrossRefPubMed Rodriguez-Blanco J, Schilling NS, Tokhunts R, Giambelli C, Long J, Liang Fei D, Singh S, Black KE, Wang Z, Galimberti F, Bejarano PA, Elliot S, Glassberg MK, Nguyen DM, Lockwood WW, Lam WL, Dmitrovsky E, Capobianco AJ, Robbins DJ: The hedgehog processing pathway is required for NSCLC growth and survival. Oncogene. 2013, 32: 2335-2345.CrossRefPubMed
19.
go back to reference Raz G, Allen KE, Kingsley C, Cherni I, Arora S, Watanabe A, Lorenzo CD, Edwards VD, Sridhar S, Hostetter G, Weiss GJ: Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer. Lung Cancer. 2012, 76: 191-196.CrossRefPubMed Raz G, Allen KE, Kingsley C, Cherni I, Arora S, Watanabe A, Lorenzo CD, Edwards VD, Sridhar S, Hostetter G, Weiss GJ: Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer. Lung Cancer. 2012, 76: 191-196.CrossRefPubMed
20.
go back to reference Gialmanidis IP, Bravou V, Amanetopoulou SG, Varakis J, Kourea H, Papadaki H: Overexpression of hedgehog pathway molecules and FOXM1 in non-small cell lung carcinomas. Lung Cancer. 2009, 66: 64-74.CrossRefPubMed Gialmanidis IP, Bravou V, Amanetopoulou SG, Varakis J, Kourea H, Papadaki H: Overexpression of hedgehog pathway molecules and FOXM1 in non-small cell lung carcinomas. Lung Cancer. 2009, 66: 64-74.CrossRefPubMed
21.
go back to reference Wang B, Fallon JF, Beachy PA: Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell. 2000, 100: 423-434.CrossRefPubMed Wang B, Fallon JF, Beachy PA: Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell. 2000, 100: 423-434.CrossRefPubMed
22.
go back to reference Iwasaki H, Nakano K, Shinkai K, Kunisawa Y, Hirahashi M, Oda Y, Onishi H, Katano M: Hedgehog Gli3 activator signal augments tumorigenicity of colorectal cancer via upregulation of adherence-related genes. Cancer Sci. 2013, 104: 328-336.CrossRefPubMed Iwasaki H, Nakano K, Shinkai K, Kunisawa Y, Hirahashi M, Oda Y, Onishi H, Katano M: Hedgehog Gli3 activator signal augments tumorigenicity of colorectal cancer via upregulation of adherence-related genes. Cancer Sci. 2013, 104: 328-336.CrossRefPubMed
23.
go back to reference Kang HN, Oh SC, Kim JS, Yoo YA: Abrogation of Gli3 expression suppresses the growth of colon cancer cells via activation of p53. Exp Cell Res. 2012, 318: 539-549.CrossRefPubMed Kang HN, Oh SC, Kim JS, Yoo YA: Abrogation of Gli3 expression suppresses the growth of colon cancer cells via activation of p53. Exp Cell Res. 2012, 318: 539-549.CrossRefPubMed
24.
go back to reference Im S, Choi HJ, Yoo C, Jung JH, Jeon YW, Suh YJ, Kang CS: Hedgehog related protein expression in breast cancer: gli-2 is associated with poor overall survival. Korean J Pathol. 2013, 47: 116-123.PubMedCentralCrossRefPubMed Im S, Choi HJ, Yoo C, Jung JH, Jeon YW, Suh YJ, Kang CS: Hedgehog related protein expression in breast cancer: gli-2 is associated with poor overall survival. Korean J Pathol. 2013, 47: 116-123.PubMedCentralCrossRefPubMed
26.
go back to reference Geissler K, Zach O: Pathways involved in drosophila and human cancer development: the notch, hedgehog, wingless, runt, and trithorax pathway. Ann Hematol. 2012, 91: 645-669.CrossRefPubMed Geissler K, Zach O: Pathways involved in drosophila and human cancer development: the notch, hedgehog, wingless, runt, and trithorax pathway. Ann Hematol. 2012, 91: 645-669.CrossRefPubMed
27.
go back to reference Bertrand FE, Angus CW, Partis WJ, Sigounas G: Developmental pathways in colon cancer: crosstalk between WNT, BMP, hedgehog and notch. Cell Cycle. 2012, 11: 4344-4351.PubMedCentralCrossRefPubMed Bertrand FE, Angus CW, Partis WJ, Sigounas G: Developmental pathways in colon cancer: crosstalk between WNT, BMP, hedgehog and notch. Cell Cycle. 2012, 11: 4344-4351.PubMedCentralCrossRefPubMed
28.
go back to reference Santoni M, Burattini L, Nabissi M, Morelli MB, Berardi R, Santoni G, Cascinu S: Essential role of Gli proteins in glioblastoma multiforme. Curr Protein Pept Sci. 2013, 14: 133-140.CrossRefPubMed Santoni M, Burattini L, Nabissi M, Morelli MB, Berardi R, Santoni G, Cascinu S: Essential role of Gli proteins in glioblastoma multiforme. Curr Protein Pept Sci. 2013, 14: 133-140.CrossRefPubMed
29.
go back to reference ten Haaf A, Bektas N, von Serenyi S, Losen I, Arweiler EC, Hartmann A, Knuchel R, Dahl E: Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival. BMC Cancer. 2009, 9: 298-PubMedCentralCrossRefPubMed ten Haaf A, Bektas N, von Serenyi S, Losen I, Arweiler EC, Hartmann A, Knuchel R, Dahl E: Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival. BMC Cancer. 2009, 9: 298-PubMedCentralCrossRefPubMed
30.
go back to reference Mori Y, Okumura T, Tsunoda S, Sakai Y, Shimada Y: Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma. Oncology. 2006, 70: 378-389.CrossRefPubMed Mori Y, Okumura T, Tsunoda S, Sakai Y, Shimada Y: Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma. Oncology. 2006, 70: 378-389.CrossRefPubMed
31.
go back to reference Ding YL, Zhou Y, Xiang L, Ji ZP, Luo ZH: Expression of glioma-associated oncogene homolog 1 is associated with invasion and postoperative liver metastasis in colon cancer. International journal of medical sciences. 2012, 9: 334-338.PubMedCentralCrossRefPubMed Ding YL, Zhou Y, Xiang L, Ji ZP, Luo ZH: Expression of glioma-associated oncogene homolog 1 is associated with invasion and postoperative liver metastasis in colon cancer. International journal of medical sciences. 2012, 9: 334-338.PubMedCentralCrossRefPubMed
32.
go back to reference He HC, Chen JH, Chen XB, Qin GQ, Cai C, Liang YX, Han ZD, Dai QS, Chen YR, Zeng GH, Zhu JG, Jiang FN, Zhong WD: Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome. Pathol Oncol Res. 2012, 18: 349-355.CrossRefPubMed He HC, Chen JH, Chen XB, Qin GQ, Cai C, Liang YX, Han ZD, Dai QS, Chen YR, Zeng GH, Zhu JG, Jiang FN, Zhong WD: Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome. Pathol Oncol Res. 2012, 18: 349-355.CrossRefPubMed
33.
go back to reference Azoulay S, Terry S, Chimingqi M, Sirab N, Faucon H, Gil Diez De Medina S, Moutereau S, Maille P, Soyeux P, Abbou C, Salomon L, Vacherot F, de la Taille A, Loric S, Allory Y: Comparative expression of hedgehog ligands at different stages of prostate carcinoma progression. J Pathol. 2008, 216: 460-470.CrossRefPubMed Azoulay S, Terry S, Chimingqi M, Sirab N, Faucon H, Gil Diez De Medina S, Moutereau S, Maille P, Soyeux P, Abbou C, Salomon L, Vacherot F, de la Taille A, Loric S, Allory Y: Comparative expression of hedgehog ligands at different stages of prostate carcinoma progression. J Pathol. 2008, 216: 460-470.CrossRefPubMed
34.
go back to reference Henkin RI: Vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012, 367: 970-Author reply 970-971PubMed Henkin RI: Vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012, 367: 970-Author reply 970-971PubMed
35.
go back to reference Berlin J, Bendell JC, Hart LL, Firdaus I, Gore I, Hermann RC, Mulcahy MF, Zalupski MM, Mackey HM, Yauch RL, Graham RA, Bray GL, Low JA: A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer. Clin Cancer Res. 2013, 19: 258-267.CrossRefPubMed Berlin J, Bendell JC, Hart LL, Firdaus I, Gore I, Hermann RC, Mulcahy MF, Zalupski MM, Mackey HM, Yauch RL, Graham RA, Bray GL, Low JA: A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer. Clin Cancer Res. 2013, 19: 258-267.CrossRefPubMed
36.
go back to reference Neal JW, Sequist LV: Exciting new targets in lung cancer therapy: ALK, IGF-1R, HDAC, and Hh. Curr Treat Options in Oncol. 2010, 11: 36-44.CrossRef Neal JW, Sequist LV: Exciting new targets in lung cancer therapy: ALK, IGF-1R, HDAC, and Hh. Curr Treat Options in Oncol. 2010, 11: 36-44.CrossRef
Metadata
Title
Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma
Authors
Masashi Ishikawa
Makoto Sonobe
Naoto Imamura
Terumasa Sowa
Kei Shikuma
Hiroshi Date
Publication date
01-12-2014
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2014
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-12-253

Other articles of this Issue 1/2014

World Journal of Surgical Oncology 1/2014 Go to the issue